查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1974053

口服固體製劑生產市場分析及預測（至2035年）：類型、產品、服務、技術、應用、劑型、材料類型、製程及最終用戶

Oral Solid Dosage Manufacturing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Form, Material Type, Process, End User
出版日期: | 出版商: Global Insight Services | 英文 332 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

口服固體製劑生產市場預計將從2024年的323億美元成長到2034年的564億美元，複合年成長率約為5.7%。口服固體製劑生產市場涵蓋穩定、便利且經濟高效的藥片和膠囊的生產。藥物製劑技術的進步、製程最佳化和法規遵循的提高是推動該行業發展的主要因素。包衣技術、連續生產和個人化醫療的創新正在重塑市場格局。慢性病盛行率的上升和學名藥需求的成長是推動市場成長的主要動力，而永續性和品質保證仍然至關重要。

口服固體製劑生產市場正經歷強勁成長，這主要得益於技術進步和對高效給藥系統日益成長的需求。速釋片劑因其應用廣泛且服用方便，成為成長最強勁的細分市場。緩釋片劑緊跟在後，有助於提高患者依從性和治療效果。膠囊製劑，尤其是硬膠囊，因其用途廣泛且便於患者使用而備受關注。針對吞嚥困難患者的口溶錠的需求也在不斷成長。在輔料方面，粘合劑和填充劑因其在製劑穩定性和藥物釋放方面發揮的關鍵作用而佔據主導地位。包衣材料是第二大成長細分市場，因為它們可以提高藥物保護和患者依從性。連續生產技術因其能夠提高效率和降低生產成本而發展迅速。對先進品管系統的投資確保了符合嚴格的監管標準，從而進一步推動了市場成長。

市場區隔
類型 速釋片、緩釋片、咀嚼片、發泡、口溶錠片、舌下片、膜衣錠、糖衣片、腸溶錠
產品 片劑、膠囊、粉末、顆粒劑、錠劑、丸劑
服務 配方開發、製程開發、分析測試、法規遵循、包裝、品質保證、供應鏈管理
科技 壓片、製粒、包衣、封裝、冷凍乾燥、微粉化、噴霧乾燥、連續生產、3D列印
目的 藥品、營養補充品、化妝品、生物製藥、非處方藥、處方藥、動物用藥品
劑型 固體，固體
材料類型 原料藥（API）、輔料、粘合劑、崩壞、潤滑劑、著色劑、包衣劑、防腐劑
流程 濕式製粒、乾式製粒、直接壓片、熱熔擠出
最終用戶 製藥公司、契約製造組織（CMO）、研發實驗室

市場概況：

口服固體製劑生產市場呈現市場佔有率分佈多元化的特點，主要受策略性定價模式和創新產品不斷湧現的影響。主要企業正致力於透過先進的製劑和給藥技術來強化產品系列。旨在拓展產品線的聯盟和夥伴關係進一步加劇了這種競爭格局。定價策略體現了這些創新產品帶來的附加價值，並與醫療服務提供者和患者不斷變化的需求相契合。口服固體製劑生產市場的競爭異常激烈，主要企業競相透過創新和策略併購來主導。監管的影響在北美和歐洲等地區尤其顯著，這些地區嚴格的監管準則塑造了市場動態。企業必須遵守這些法規，這反過來又推動了品質改進和合規性提升。在生產製程技術進步和大量新藥核准的推動下，該市場展現出成長勢頭，並預示著一個充滿活力的未來。

主要趨勢和促進因素：

口服固體製劑生產市場正經歷強勁成長，這主要得益於幾個關鍵趨勢和促進因素。其中一個顯著趨勢是，由於關鍵藥物的專利到期，對學名藥的需求不斷成長。這導致學名藥生產激增，刺激了市場競爭和創新。此外，藥物製劑技術的進步提高了口服固體製劑的生物利用度和穩定性，促使製藥公司投資現代化的生產技術。慢性病的日益增多也是關鍵促進因素，需要開發有效的口服固體製劑用於長期治療。全球老齡化人口的成長也推動了市場發展，因為老齡化人口增加了對便捷易用藥物劑型的需求。此外，監管機構對口服固體製劑核准的支持正在簡化開發流程，並鼓勵製藥公司擴展產品系列。連續生產流程的日益普及提高了生產效率並降低了營運成本，為市場參與者提供了豐厚的機會。

限制與挑戰：

口服固體製劑生產市場面臨許多重大限制與挑戰。其中一個關鍵問題是嚴格的法規環境，要求企業嚴格遵守相關規定，導致生產成本上升。這種複雜性可能會阻礙新進入者，並限制創新。此外，市場還面臨供應鏈中斷的問題，全球事件加劇了這個問題，導致生產延誤和成本增加。學名藥的日益激烈的競爭給價格和市場佔有率帶來了壓力。這種競爭要求企業持續投資研發，以維持競爭優勢。所有這些因素共同阻礙了口服固體製劑生產市場的成長和擴張。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 快速起效配方
    • 緩釋製劑
    • 咀嚼片
    • 發泡
    • 口溶錠
    • 舌下片
    • 膜衣錠
    • 糖霜片
    • 腸溶片
  • 市場規模及預測：依產品分類
    • 藥片
    • 膠囊
    • 粉末
    • 顆粒
    • 錠劑
    • 顆粒
  • 市場規模及預測：依服務分類
    • 配方開發
    • 製程開發
    • 分析測試
    • 監理合規
    • 包裝
    • 品質保證
    • 供應鏈管理
  • 市場規模及預測：依技術分類
    • 壓縮
    • 顆粒化
    • 塗層
    • 封裝
    • 冷凍乾燥
    • 微粉化
    • 噴霧乾燥
    • 連續製造
    • 3D列印
  • 市場規模及預測：依應用領域分類
    • 製藥
    • 營養保健品
    • 藥用化妝品
    • 生物製藥
    • 非處方藥
    • 處方藥
    • 動物用藥品
  • 市場規模及預測：依類型
    • 固態劑型
    • 半固態
  • 市場規模及預測：依材料類型分類
    • 原料藥（API）
    • 添加劑
    • 粘合劑
    • 崩壞
    • 潤滑劑
    • 著色劑
    • 塗層劑
    • 防腐劑
  • 市場規模及預測：依製程分類
    • 濕式製粒
    • 乾式製粒
    • 直接壓縮
    • 熱熔擠出
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 契約製造組織（CMO）
    • 研究與開發實驗室

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Catalent Pharma Solutions
  • Lonza Group
  • Aenova Group
  • Recipharm AB
  • Patheon by Thermo Fisher Scientific
  • Almac Group
  • Piramal Pharma Solutions
  • Famar Health Care Services
  • Hovione
  • Capsugel by Lonza
  • NextPharma Technologies
  • Fareva
  • CordenPharma
  • Dishman Carbogen Amcis
  • Delpharm

第9章：關於我們

簡介目錄
Product Code: GIS34110

Oral Solid Dosage Manufacturing Market is anticipated to expand from $32.3 billion in 2024 to $56.4 billion by 2034, growing at a CAGR of approximately 5.7%. The Oral Solid Dosage Manufacturing Market encompasses the production of pharmaceutical tablets and capsules, renowned for their stability, convenience, and cost-effectiveness. This sector is driven by advancements in drug formulation, process optimization, and regulatory compliance. Innovations in coating technologies, continuous manufacturing, and personalized medicine are shaping the landscape. The rising prevalence of chronic diseases and increasing demand for generic medications are propelling market growth, while sustainability and quality assurance remain pivotal.

The Oral Solid Dosage Manufacturing Market is experiencing robust growth, fueled by technological advancements and increasing demand for efficient drug delivery systems. The immediate-release tablets segment is the top-performing, driven by its widespread use and ease of administration. Sustained-release tablets follow, with their ability to enhance patient compliance and therapeutic efficacy. Capsule formulations, particularly hard capsules, are gaining traction due to their versatility and patient-friendly nature. The market is also seeing a rise in demand for orally disintegrating tablets, catering to populations with swallowing difficulties. Among excipients, binders and fillers are leading, given their critical role in formulation stability and drug release. Coating materials are the second highest-performing sub-segment, as they enhance drug protection and patient compliance. Continuous manufacturing technologies are gaining momentum, offering increased efficiency and reduced production costs. Investments in advanced quality control systems are further propelling market growth, ensuring compliance with stringent regulatory standards.

Market Segmentation
TypeImmediate Release, Modified Release, Chewable Tablets, Effervescent Tablets, Orally Disintegrating Tablets, Sublingual Tablets, Film-Coated Tablets, Sugar-Coated Tablets, Enteric-Coated Tablets
ProductTablets, Capsules, Powders, Granules, Lozenges, Pellets
ServicesFormulation Development, Process Development, Analytical Testing, Regulatory Compliance, Packaging, Quality Assurance, Supply Chain Management
TechnologyCompression, Granulation, Coating, Encapsulation, Lyophilization, Micronization, Spray Drying, Continuous Manufacturing, 3D Printing
ApplicationPharmaceutical, Nutraceutical, Cosmeceutical, Biopharmaceutical, OTC Drugs, Prescription Drugs, Veterinary Medicine
FormSolid, Semi-Solid
Material TypeActive Pharmaceutical Ingredients (APIs), Excipients, Binders, Disintegrants, Lubricants, Colorants, Coating Agents, Preservatives
ProcessWet Granulation, Dry Granulation, Direct Compression, Hot Melt Extrusion
End UserPharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Research and Development Laboratories

Market Snapshot:

The Oral Solid Dosage Manufacturing Market is characterized by a diverse market share distribution, influenced by strategic pricing models and the continuous introduction of innovative products. Key players are focusing on enhancing their portfolios with advanced formulations and delivery technologies. This competitive landscape is further enriched by collaborations and partnerships aimed at expanding product offerings. The pricing strategies are reflective of the value-added benefits these novel products bring, aligning with the evolving demands of healthcare providers and patients alike. Competition within the Oral Solid Dosage Manufacturing Market is intense, with major companies vying for dominance through innovation and strategic mergers. Regulatory influences play a significant role, particularly in regions like North America and Europe, where stringent guidelines shape market dynamics. Companies are compelled to adhere to these regulations, which drive quality enhancements and compliance. The market is poised for growth, supported by technological advancements in manufacturing processes and a robust pipeline of new drug approvals, promising a vibrant future.

Geographical Overview:

The Oral Solid Dosage Manufacturing Market is witnessing notable growth across various regions, each characterized by unique dynamics. North America remains a dominant force, driven by advanced pharmaceutical infrastructure and substantial investments in drug development. The region's focus on innovation and quality in manufacturing processes further solidifies its market leadership. Europe follows closely, with strong regulatory frameworks and a commitment to high manufacturing standards. The region's emphasis on sustainable practices and technological advancements enhances its market position. In Asia Pacific, the market is expanding rapidly, propelled by increasing healthcare investments and a burgeoning pharmaceutical industry. Countries like China and India are emerging as significant players, offering lucrative opportunities due to their large patient populations and cost-effective manufacturing capabilities. Latin America and the Middle East & Africa are emerging markets with growing potential. Latin America benefits from rising healthcare expenditures and improving regulatory environments, while the Middle East & Africa are recognizing the importance of pharmaceutical manufacturing in supporting regional healthcare needs and economic development.

Key Trends and Drivers:

The Oral Solid Dosage Manufacturing Market is experiencing robust growth due to several key trends and drivers. A significant trend is the increasing demand for generic medications, driven by the expiration of patents for major drugs. This has led to a surge in generic drug manufacturing, fostering competition and innovation within the market. Additionally, advancements in drug formulation technologies are enhancing the bioavailability and stability of oral solid dosages, attracting pharmaceutical companies to invest in modern manufacturing techniques. The growing prevalence of chronic diseases is another critical driver, necessitating the development of effective oral solid dosage forms for long-term treatment. The market is also benefiting from the rising global geriatric population, which requires convenient and easy-to-administer medication forms. Furthermore, regulatory support for the approval of oral solid dosage drugs is streamlining the development process, encouraging pharmaceutical firms to expand their product portfolios. The increasing adoption of continuous manufacturing processes is enhancing production efficiency and reducing operational costs, offering lucrative opportunities for market players.

Restraints and Challenges:

The Oral Solid Dosage Manufacturing Market encounters several significant restraints and challenges. A primary concern is the stringent regulatory environment, which necessitates rigorous compliance and increases the cost of production. This complexity can deter new entrants and limit innovation. Additionally, the market faces supply chain disruptions, exacerbated by global events, leading to delays and increased costs. Furthermore, the rising cost of raw materials poses a significant challenge, squeezing profit margins and affecting pricing strategies. The market also grapples with the need for advanced technology and equipment, which demands substantial capital investment and skilled personnel. This requirement can be prohibitive for smaller manufacturers. Lastly, the increasing competition from generic and over-the-counter drugs adds pressure on pricing and market share. This competition necessitates continuous investment in research and development to maintain a competitive edge. These factors collectively impede the growth and expansion of the Oral Solid Dosage Manufacturing Market.

Key Players:

Catalent Pharma Solutions, Lonza Group, Aenova Group, Recipharm AB, Patheon by Thermo Fisher Scientific, Almac Group, Piramal Pharma Solutions, Famar Health Care Services, Hovione, Capsugel by Lonza, NextPharma Technologies, Fareva, CordenPharma, Dishman Carbogen Amcis, Delpharm

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Form
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by End User

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Immediate Release
    • 4.1.2 Modified Release
    • 4.1.3 Chewable Tablets
    • 4.1.4 Effervescent Tablets
    • 4.1.5 Orally Disintegrating Tablets
    • 4.1.6 Sublingual Tablets
    • 4.1.7 Film-Coated Tablets
    • 4.1.8 Sugar-Coated Tablets
    • 4.1.9 Enteric-Coated Tablets
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Tablets
    • 4.2.2 Capsules
    • 4.2.3 Powders
    • 4.2.4 Granules
    • 4.2.5 Lozenges
    • 4.2.6 Pellets
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Formulation Development
    • 4.3.2 Process Development
    • 4.3.3 Analytical Testing
    • 4.3.4 Regulatory Compliance
    • 4.3.5 Packaging
    • 4.3.6 Quality Assurance
    • 4.3.7 Supply Chain Management
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Compression
    • 4.4.2 Granulation
    • 4.4.3 Coating
    • 4.4.4 Encapsulation
    • 4.4.5 Lyophilization
    • 4.4.6 Micronization
    • 4.4.7 Spray Drying
    • 4.4.8 Continuous Manufacturing
    • 4.4.9 3D Printing
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Pharmaceutical
    • 4.5.2 Nutraceutical
    • 4.5.3 Cosmeceutical
    • 4.5.4 Biopharmaceutical
    • 4.5.5 OTC Drugs
    • 4.5.6 Prescription Drugs
    • 4.5.7 Veterinary Medicine
  • 4.6 Market Size & Forecast by Form (2020-2035)
    • 4.6.1 Solid
    • 4.6.2 Semi-Solid
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Active Pharmaceutical Ingredients (APIs)
    • 4.7.2 Excipients
    • 4.7.3 Binders
    • 4.7.4 Disintegrants
    • 4.7.5 Lubricants
    • 4.7.6 Colorants
    • 4.7.7 Coating Agents
    • 4.7.8 Preservatives
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Wet Granulation
    • 4.8.2 Dry Granulation
    • 4.8.3 Direct Compression
    • 4.8.4 Hot Melt Extrusion
  • 4.9 Market Size & Forecast by End User (2020-2035)
    • 4.9.1 Pharmaceutical Companies
    • 4.9.2 Contract Manufacturing Organizations (CMOs)
    • 4.9.3 Research and Development Laboratories

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Form
      • 5.2.1.7 Material Type
      • 5.2.1.8 Process
      • 5.2.1.9 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Form
      • 5.2.2.7 Material Type
      • 5.2.2.8 Process
      • 5.2.2.9 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Form
      • 5.2.3.7 Material Type
      • 5.2.3.8 Process
      • 5.2.3.9 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Form
      • 5.3.1.7 Material Type
      • 5.3.1.8 Process
      • 5.3.1.9 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Form
      • 5.3.2.7 Material Type
      • 5.3.2.8 Process
      • 5.3.2.9 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Form
      • 5.3.3.7 Material Type
      • 5.3.3.8 Process
      • 5.3.3.9 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Form
      • 5.4.1.7 Material Type
      • 5.4.1.8 Process
      • 5.4.1.9 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Form
      • 5.4.2.7 Material Type
      • 5.4.2.8 Process
      • 5.4.2.9 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Form
      • 5.4.3.7 Material Type
      • 5.4.3.8 Process
      • 5.4.3.9 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Form
      • 5.4.4.7 Material Type
      • 5.4.4.8 Process
      • 5.4.4.9 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Form
      • 5.4.5.7 Material Type
      • 5.4.5.8 Process
      • 5.4.5.9 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Form
      • 5.4.6.7 Material Type
      • 5.4.6.8 Process
      • 5.4.6.9 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Form
      • 5.4.7.7 Material Type
      • 5.4.7.8 Process
      • 5.4.7.9 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Form
      • 5.5.1.7 Material Type
      • 5.5.1.8 Process
      • 5.5.1.9 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Form
      • 5.5.2.7 Material Type
      • 5.5.2.8 Process
      • 5.5.2.9 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Form
      • 5.5.3.7 Material Type
      • 5.5.3.8 Process
      • 5.5.3.9 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Form
      • 5.5.4.7 Material Type
      • 5.5.4.8 Process
      • 5.5.4.9 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Form
      • 5.5.5.7 Material Type
      • 5.5.5.8 Process
      • 5.5.5.9 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Form
      • 5.5.6.7 Material Type
      • 5.5.6.8 Process
      • 5.5.6.9 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Form
      • 5.6.1.7 Material Type
      • 5.6.1.8 Process
      • 5.6.1.9 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Form
      • 5.6.2.7 Material Type
      • 5.6.2.8 Process
      • 5.6.2.9 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Form
      • 5.6.3.7 Material Type
      • 5.6.3.8 Process
      • 5.6.3.9 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Form
      • 5.6.4.7 Material Type
      • 5.6.4.8 Process
      • 5.6.4.9 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Form
      • 5.6.5.7 Material Type
      • 5.6.5.8 Process
      • 5.6.5.9 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Catalent Pharma Solutions
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Lonza Group
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Aenova Group
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Recipharm AB
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Patheon by Thermo Fisher Scientific
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Almac Group
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Piramal Pharma Solutions
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Famar Health Care Services
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Hovione
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Capsugel by Lonza
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 NextPharma Technologies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Fareva
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 CordenPharma
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Dishman Carbogen Amcis
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Delpharm
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us